Evidence map›Paper›PMID 39971396›Full record

ArticleEuropean respiratory review : an official journal of the European Respiratory Society2025

The impact of lung surgery, with or without (neo-)adjuvant therapy, on physical functioning in patients with nonsmall cell lung cancer: a scoping review.

Sarah Haesevoets, Eva Arents, Dries Cops, Kirsten Quadflieg, Maarten Criel, David Ruttens, Marc Daenen, Dieter Stevens, Veerle Surmont, Heleen Demeyer and 1 more

Abstract readScoping Review
In one paragraph

Article in European respiratory review : an official journal of the European Respiratory Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. The prognostic value of physical functioning on survival in patients with nonsmall cell lung cancer: a systematic review and meta-analysis.European respiratory review : an official journal of the European Respiratory Society · 2026
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sarah HaesevoetsREVAL - Rehabilitation Research Center, Faculty of Rehabilitation Sciences, Hasselt University, Diepenbeek, Belgium.ORCID https://orcid.org/0000-0002-6841-9161
Eva ArentsDepartment of Rehabilitation Sciences, Ghent University, Ghent, Belgium.ORCID https://orcid.org/0000-0001-8539-937X
Dries CopsREVAL - Rehabilitation Research Center, Faculty of Rehabilitation Sciences, Hasselt University, Diepenbeek, Belgium.ORCID https://orcid.org/0000-0002-0044-0677
Kirsten QuadfliegREVAL - Rehabilitation Research Center, Faculty of Rehabilitation Sciences, Hasselt University, Diepenbeek, Belgium.ORCID https://orcid.org/0000-0002-3905-3180
Maarten CrielDepartment Lung Diseases, Ziekenhuis Oost-Limburg, Genk, Belgium.
David RuttensDepartment Lung Diseases, Ziekenhuis Oost-Limburg, Genk, Belgium.
Marc DaenenDepartment Lung Diseases, Ziekenhuis Oost-Limburg, Genk, Belgium.
Dieter StevensDepartment Lung Diseases, UZ Ghent, Ghent, Belgium.
Veerle SurmontDepartment Lung Diseases, UZ Ghent, Ghent, Belgium.
Heleen DemeyerDepartment of Rehabilitation Sciences, Ghent University, Ghent, Belgium.ORCID https://orcid.org/0000-0001-8925-0564
Chris BurtinREVAL - Rehabilitation Research Center, Faculty of Rehabilitation Sciences, Hasselt University, Diepenbeek, Belgium chris.burtin@uhasselt.be.ORCID https://orcid.org/0000-0002-1342-8554

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients with early stage (I-IIIA) nonsmall cell lung cancer (NSCLC) are typically treated

objectiveThis scoping review aimed to synthesise evidence concerning the effects of lung surgery, with or without (neo-)adjuvant therapy, on the PF of patients with NSCLC.

methodsPubMed, Web of Science and Cochrane databases were systematically searched from inception until 1 July 2023. A comprehensive framework based on the International Classification of Functioning, Disability, and Health was used to define various aspects of PF. Longitudinal studies, reporting PF prior to and after NSCLC treatment, and cross-sectional studies reporting PF after treatment were included.

results85 included studies assessed the effects of surgery with (n=7) or without (n=78) (neo-) adjuvant therapy on body function (n=29), activity (n=67) and/or participation (n=15). 98% of reported outcomes within the longitudinal studies indicate a decline in PF, with 52% demonstrating significant deteriorations, with follow-up times ranging from immediately post-operative up to 1 year after treatment. Cross-sectional studies show impaired PF in 71% of reported outcomes.

conclusionPF of patients with NSCLC tends to deteriorate following lung surgery, irrespective of additional (neo-)adjuvant therapy. While the negative impact of lung surgery on ICF categories of "body function" and "activity" have been described to some depth, insights into the impact on "participation" are lacking.

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsNeoadjuvant TherapyPneumonectomyHumansTreatment Outcome

Identifiers

PMID39971396
PMCPMC11836670

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.